MD970254A - Utilizare a melatoninei pentru trata-mentul pacientilor dependenti de me-di-ca-men-te - Google Patents
Utilizare a melatoninei pentru trata-mentul pacientilor dependenti de me-di-ca-men-teInfo
- Publication number
- MD970254A MD970254A MD97-0254A MD970254A MD970254A MD 970254 A MD970254 A MD 970254A MD 970254 A MD970254 A MD 970254A MD 970254 A MD970254 A MD 970254A
- Authority
- MD
- Moldova
- Prior art keywords
- dependence
- melatonine
- patients
- treatment
- medicamental
- Prior art date
Links
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 title abstract 2
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 title abstract 2
- 229960003987 melatonin Drugs 0.000 title abstract 2
- 206010052804 Drug tolerance Diseases 0.000 abstract 1
- 206010013663 drug dependence Diseases 0.000 abstract 1
- 208000011117 substance-related disease Diseases 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/381,535 US6469044B1 (en) | 1995-02-01 | 1995-02-01 | Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies |
| EP95303853A EP0724878B1 (en) | 1995-02-01 | 1995-06-06 | Use of melatonin for treating patients suffering from drug dependencies |
| PCT/IB1996/000082 WO1996023496A1 (en) | 1995-02-01 | 1996-01-29 | Use of melatonin for treating patients suffering from drug addiction |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| MD970254A true MD970254A (ro) | 1999-05-31 |
| MD1716B2 MD1716B2 (ro) | 2001-08-31 |
| MD1716C2 MD1716C2 (ro) | 2002-02-28 |
Family
ID=26140195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MD97-0254A MD1716C2 (ro) | 1995-02-01 | 1996-01-29 | Utilizare a melatoninei pentru tratamentul pacienţilor dependenţi de benzodiazepine |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JP4516159B2 (ro) |
| CN (1) | CN1083263C (ro) |
| AT (1) | AT408188B (ro) |
| AU (1) | AU695366B2 (ro) |
| BG (1) | BG62876B1 (ro) |
| BR (1) | BR9607169A (ro) |
| CZ (1) | CZ291349B6 (ro) |
| DK (1) | DK176081B1 (ro) |
| EE (1) | EE03384B1 (ro) |
| FI (1) | FI119586B (ro) |
| IS (1) | IS1980B (ro) |
| LU (1) | LU90118B1 (ro) |
| LV (1) | LV11940B (ro) |
| MD (1) | MD1716C2 (ro) |
| NO (1) | NO312814B1 (ro) |
| NZ (1) | NZ298878A (ro) |
| PL (1) | PL183148B1 (ro) |
| SI (1) | SI9620022A (ro) |
| SK (1) | SK284521B6 (ro) |
| TR (1) | TR199700723T1 (ro) |
| TW (1) | TW483757B (ro) |
| WO (1) | WO1996023496A1 (ro) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1272177E (pt) | 2000-01-05 | 2007-07-11 | Neurim Pharma 1991 | Método e formulação para o tratamento da resistência aos antihipertensos e condições associadas. |
| IL149377A (en) * | 2002-04-28 | 2012-10-31 | Neurim Pharma 1991 | Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds |
| IL155666A (en) | 2003-04-29 | 2013-12-31 | Neurim Pharma 1991 | Insomnia treatment |
| US9119846B2 (en) | 2003-04-29 | 2015-09-01 | Neurim Pharmaceuticals (1991) Ltd. | Method and composition for enhancing cognition in alzheimer's patients |
| US11918557B2 (en) | 2012-01-26 | 2024-03-05 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
| KR102593047B1 (ko) | 2012-01-26 | 2023-10-24 | 반다 파마슈티칼즈, 인코퍼레이티드. | 일주기 리듬 장애의 치료 |
| WO2014100292A1 (en) | 2012-12-18 | 2014-06-26 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
| US10376487B2 (en) | 2013-11-12 | 2019-08-13 | Vanda Pharmaceuticals Inc. | Method of treatment |
| US11090285B2 (en) | 2013-11-12 | 2021-08-17 | Vanda Pharmaceuticals Inc | Treatment of circadian rhythm disorders |
| SG11201903829PA (en) * | 2016-10-31 | 2019-05-30 | Neurim Pharma 1991 | Melatonin mini-tablets and method of manufacturing the same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE181670T1 (de) * | 1991-05-09 | 1999-07-15 | Neurim Pharma 1991 | Melatonin enthaltende arzneimittel |
| IT1251544B (it) * | 1991-05-13 | 1995-05-17 | Gabriele Biella | Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico |
-
1996
- 1996-01-29 MD MD97-0254A patent/MD1716C2/ro not_active IP Right Cessation
- 1996-01-29 TR TR97/00723T patent/TR199700723T1/xx unknown
- 1996-01-29 EE EE9700166A patent/EE03384B1/xx not_active IP Right Cessation
- 1996-01-29 AT AT0901396A patent/AT408188B/de not_active IP Right Cessation
- 1996-01-29 SI SI9620022A patent/SI9620022A/sl not_active IP Right Cessation
- 1996-01-29 NZ NZ298878A patent/NZ298878A/xx not_active IP Right Cessation
- 1996-01-29 JP JP52338596A patent/JP4516159B2/ja not_active Expired - Lifetime
- 1996-01-29 BR BR9607169A patent/BR9607169A/pt not_active Application Discontinuation
- 1996-01-29 SK SK1030-97A patent/SK284521B6/sk unknown
- 1996-01-29 PL PL96321630A patent/PL183148B1/pl unknown
- 1996-01-29 CZ CZ19972405A patent/CZ291349B6/cs not_active IP Right Cessation
- 1996-01-29 CN CN96191750A patent/CN1083263C/zh not_active Expired - Lifetime
- 1996-01-29 WO PCT/IB1996/000082 patent/WO1996023496A1/en not_active Ceased
- 1996-01-29 AU AU44574/96A patent/AU695366B2/en not_active Expired
- 1996-04-12 TW TW085104319A patent/TW483757B/zh not_active IP Right Cessation
-
1997
- 1997-07-24 LV LVP-97-144A patent/LV11940B/en unknown
- 1997-07-25 IS IS4532A patent/IS1980B/is unknown
- 1997-07-30 DK DK199700896A patent/DK176081B1/da not_active IP Right Cessation
- 1997-07-30 BG BG101803A patent/BG62876B1/bg unknown
- 1997-07-31 NO NO19973531A patent/NO312814B1/no not_active IP Right Cessation
- 1997-07-31 FI FI973185A patent/FI119586B/fi not_active IP Right Cessation
- 1997-08-01 LU LU90118A patent/LU90118B1/fr active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU94038043A (ru) | Применение замещенных производных аденина для лечения множественного склероза | |
| ES2165910T3 (es) | Administracion nasal y ocular de cetamina para el tratamiento del dolor y para la desintoxicacion. | |
| PT998287E (pt) | Utilizacao de levobupivacaina | |
| HUT77927A (hu) | Nebivolol-származékok alkalmazása antiatherogén hatású gyógyászati készítmények előállítására és e vegyületeket tartalmazó kombinációs gyógyászati készítmények | |
| BG101118A (en) | Therapeutical compounds | |
| AU677279B2 (en) | Application of carbamazepine and oxcarbazepine in the treatment of Parkinson's disease and Parkinsonian syndromes | |
| NO20101190L (no) | Anvendelse av buprenorfin i fremstillingen av et medikament | |
| IL127714A0 (en) | Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic depressive bipolar disorders | |
| EP1085862A4 (en) | METHODS OF TREATING AUTOIMMUNE DISEASES | |
| ES2160643T3 (es) | Composiciones que contienen g-csf y proteina de union al tnf. | |
| AU4024797A (en) | Use of arachidonic acid and/or docosahexanoic acid for the manufacture of a medicament for the treatment of dyspraxia | |
| MD970254A (ro) | Utilizare a melatoninei pentru trata-mentul pacientilor dependenti de me-di-ca-men-te | |
| GB0020504D0 (en) | Therapeutic method | |
| AU2001261987A1 (en) | Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders | |
| AU2787495A (en) | Use of copolymer-1 for the manufacture of a medicament for the treatment of optic neuritis | |
| NO990450L (no) | Behandling av sinnslidelser | |
| TW330933B (en) | Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes | |
| AU7718796A (en) | 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus | |
| NO984651L (no) | Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet | |
| AU5890499A (en) | Use of composition in the treatment of schizophrenia | |
| UA22223A (uk) | Спосіб лікуваhhя захворюваhь оргаhа зору | |
| UA30361A (uk) | Спосіб лікування глікозидної інтоксикації | |
| MX9503363A (es) | N-(2,6-dioxo-3-piperidil) ftalimida (generico talidomida como tratamiento del sindrome de desgaste asociado con la infeccion por vih-1. | |
| ZA983211B (en) | Use of mizolastine for preparing medication for the treatment of inflammation | |
| IL128494A0 (en) | Use of inhibitors of pkc for the manufacture of a medicament for the treatment of central nervous system diseases associated with hiv infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PD99 | Pending application | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |